Pixalate's April 2024 Global Mobile Publisher Trust Index for Apple App Store and Google Play Store: Candy Crush, Weather Radar Rank No. 1 in North America
May 15, 2024 16:00 ET
|
Pixalate Inc.
LONDON, May 15, 2024 (GLOBE NEWSWIRE) -- Pixalate, the market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and mobile advertising, today released the...
Pixalate’s April 2024 Top Grossing Connected TV (CTV) Apps Based on Global Open Programmatic Ad Revenue: Hulu, Vix Among Top Grossing Apps
May 15, 2024 13:18 ET
|
Pixalate Inc.
LONDON, May 15, 2024 (GLOBE NEWSWIRE) -- Pixalate, the market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising, today released the...
Pixalate’s April 2024 Global Top Grossing Mobile Apps Based on Open Programmatic Ad Revenue in the Apple App Store and Google Play Store: ‘Happy Color’, ‘SnackVideo’ Among Top Grossing Apps in North America & APAC
May 15, 2024 13:01 ET
|
Pixalate Inc.
LONDON, May 15, 2024 (GLOBE NEWSWIRE) -- Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today released the April 2024 Global Top Grossing Mobile...
Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
May 15, 2024 12:17 ET
|
Cooper Aerobics
New research from The Cooper Institute® + partners shows exercising, even at very high levels, is unrelated to progression of coronary artery calcium (CAC)
Novartis highlights pioneering innovation in CML with data from Scemblix® Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA
May 15, 2024 10:00 ET
|
Novartis Pharma AG
Primary results of the Scemblix® ASC4FIRST pivotal Phase III study in first-line Ph+ CML-CP supporting third US FDA Breakthrough Therapy designation, to be detailed in the ASCO Press Program and the...
CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024 16:05 ET
|
Cargo Therapeutics, Inc.
CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
May 14, 2024 10:00 ET
|
Saladax Biomedical, Inc.
Bethlehem, PA, May 14, 2024 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc. (Saladax) is pleased to announce that Health Canada has approved Saladax’s 5-Fluorouracil (My5-FU) Assay for sale in Canada...
Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting
May 14, 2024 10:00 ET
|
Kymera Therapeutics, Inc.
Abstract released today highlights safety, pharmacodynamic and clinical response data collected through February 6, 2024 cut-off date Updated data to be presented at the European Hematology...
ProLiteracy Presents First Award for Adult Literacy Research
May 14, 2024 09:45 ET
|
ProLiteracy
ProLiteracy awarded a group of researchers the Dollar General Research to Practice Award for "The Effects of an Adult Literacy App on Word Decoding."
Shuttle Pharma Provides First Quarter 2024 Corporate Update
May 14, 2024 09:00 ET
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., May 14, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...